Related Experiment Video

Updated: May 28, 2025

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

1.6K

The Year in Cardiology-Practice Changing Trials from European Society of Cardiology Congress 2023

Akshyaya Pradhan1, Umesh Tripathi1, Abhishek Singh1

  • 1Department of Cardiology, King George's Medical University, Lucknow, Uttar Pradesh, India.

The International Journal of Angiology : Official Publication of the International College of Angiology, Inc
|February 13, 2025
PubMed

Insights

This review summarizes 10 pivotal cardiology trials presented at the European Society of Cardiology congress, highlighting advances that may change clinical practice.

Area of Science:

  • Cardiology
  • Clinical Trials
  • Cardiovascular Medicine

Background:

  • The European Society of Cardiology (ESC) congress is a key event for sharing cardiology research.
  • Numerous clinical trials are presented annually, influencing medical practice.
  • Last year's congress featured over 30 trials across diverse cardiovascular areas.

Purpose of the Study:

  • To summarize 10 significant clinical trials from the ESC congress.
  • To discuss the potential impact of these trials on daily cardiology practice.
  • To offer perspectives on future directions in cardiovascular medicine.

Main Methods:

  • Review of major clinical trials presented at the ESC annual congress.
  • Selection of 10 trials deemed most impactful for clinical practice.
  • Analysis of trial findings and their implications.

Main Results:

  • Over 30 clinical trials were presented, covering heart failure, lipid management, coronary intervention, and more.
  • Ten key trials were identified for their potential to significantly alter cardiology practice.
  • The presented trials offer insights into advancements in anticoagulation, atrial fibrillation, and antiplatelet therapy.

Conclusions:

  • The ESC congress serves as a vital platform for disseminating practice-changing cardiovascular research.
  • Key trials presented offer valuable insights and future directions for managing various cardiac conditions.
  • Continuous evaluation of trial data is essential for advancing cardiovascular care.

Keywords:
acute heart failurebifurcation lesioncardiac myosin inhibitorscomplete revascularizationfrailtypostprocedural anticoagulationsemaglutidestatinsstent thrombosissubclinical AF

More Related Videos

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System10:17

Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System

Published on: April 11, 2025

365
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.2K

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.6K
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
287
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
86
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
512